IRADIMED CORP
IRMD
DELAYED 1 MONTH

11 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 4 8:21 PMHilda Frederique Scharen-GuivelDirector
Sale
3,000$95.00$285.0K5,598(D)

View →

Jun 1, 2026Jun 2 6:26 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
2,500$90.60$226.5K2,162,500(I)

View →

May 27, 2026May 28 7:08 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
2,500$91.95$229.9K2,165,000(I)

View →

May 26, 2026May 28 7:08 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
5,000$92.23$461.2K2,167,500(I)

View →

May 19, 2026May 20 8:38 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
2,500$87.88$219.7K2,172,500(I)

View →

May 18, 2026May 20 8:38 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
5,000$87.51$437.6K2,175,000(I)

View →

May 12, 2026May 13 8:30 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
4,411$83.92$370.2K2,180,000(I)

View →

May 11, 2026May 13 8:30 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
3,089$84.54$261.2K2,184,411(I)

View →

May 5, 2026May 6 5:51 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
3,750$85.74$321.5K2,187,500(I)

View →

May 4, 2026May 6 5:51 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
3,750$85.69$321.3K2,191,250(I)

View →

Apr 28, 2026Apr 30 6:30 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
3,750$86.23$323.4K2,195,000(I)

View →

Apr 27, 2026Apr 30 6:30 PMRoger E. SusiDirector, CEO, President, Chairman, 10% Owner
Sale
3,750$89.16$334.3K2,198,750(I)

View →

Mar 10, 2026Mar 10 8:05 PMRoger E. SusiDirector, CEO, PRESIDENT, CHAIRMAN, 10% Owner
Sale
2,500$100.11$250.3K2,247,500(I)

View →

Mar 9, 2026Mar 10 8:05 PMRoger E. SusiDirector, CEO, PRESIDENT, CHAIRMAN, 10% Owner
Sale
5,000$100.04$500.2K2,250,000(I)

View →

Mar 6, 2026Mar 9 8:30 PMRoger E. SusiDirector, CEO, PRESIDENT, CHAIRMAN, 10% Owner
Sale
7,500$98.39$737.9K2,255,000(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 5 7:44 PMJeff ChiprinChief Commercial Officer
Grant/Award
1,150—1,150(D)

View →

Mar 3, 2026Mar 5 7:42 PMJohn GlennCHIEF FINANCIAL OFFICER
Grant/Award
8,907—8,907(D)

View →